Blog Posts
Agenus
Photo taken from Agenus/LinkedIn

Agenus – CTEP has announced the availability of botensilimab for clinical studies

Agenus shared on LinkedIn:

“The National Cancer Institute (NCI)‘s Cancer Therapy Evaluation Program (CTEP) has announced the availability of our therapy, botensilimab, for clinical studies. ”.

Read further.
Source: Agenus/LinkedIn

Agenus cancer Cancer Therapy Evaluation Program clinical studies National Cancer Institute (NCI) OncoDaily Oncology